85 related articles for article (PubMed ID: 16612145)
1. Characterization of antibodies to CA 125 that bind preferentially to the cell-associated form of the antigen.
Singleton J; Guillen DE; Scully MS; Xue J; Moffet J; Chen C; Patel SR; Schilling A; Corisdeo S; Yang Q; Wang B; Soltis DA; Albone EF
Tumour Biol; 2006; 27(3):122-32. PubMed ID: 16612145
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of three novel monoclonal antibodies against CA-125.
Michurina T; Kerzhner M; Klimovich B
Monoclon Antib Immunodiagn Immunother; 2014 Oct; 33(5):319-24. PubMed ID: 25357999
[TBL] [Abstract][Full Text] [Related]
3. Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine.
Nustad K; Bast RC; Brien TJ; Nilsson O; Seguin P; Suresh MR; Saga T; Nozawa S; Børmer OP; de Bruijn HW; Nap M; Vitali A; Gadnell M; Clark J; Shigemasa K; Karlsson B; Kreutz FT; Jette D; Sakahara H; Endo K; Paus E; Warren D; Hammarström S; Kenemans P; Hilgers J
Tumour Biol; 1996; 17(4):196-219. PubMed ID: 8685601
[TBL] [Abstract][Full Text] [Related]
4. Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen.
Suzuki N; Tamada Y; Shigirahara K; Suzuki A; Susumu N; Ishida I; Aoki D
Int J Gynecol Cancer; 2008; 18(5):996-1006. PubMed ID: 18028379
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of monoclonal antibodies against the extracellular domain of CA 125.
Shojaeian S; Allameh A; Zarnani AH; Chamankhah M; Ghods R; Bayat AA; Jeddi-Tehrani M
Immunol Invest; 2010 Jan; 39(2):114-31. PubMed ID: 20136619
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antiidiotypic antibody ACA 125 mimicking the tumor-associated antigen CA 125 for immunotherapy of ovarian cancer.
Schlebusch H; Wagner U; Grünn U; Schultes B
Hybridoma; 1995 Apr; 14(2):167-74. PubMed ID: 7590775
[TBL] [Abstract][Full Text] [Related]
7. Heterologous immunization, a way out of the problem of monoclonal antibody production against carcinoma antigen 125.
Shojaeian S; Zarnani AH; Jeddi-Tehrani M; Fereidooni F; Torkabadi E; Akhondi MM; Tabatabaei-Panah AS; Allameh A
Iran J Immunol; 2009 Dec; 6(4):174-85. PubMed ID: 20054105
[TBL] [Abstract][Full Text] [Related]
8. Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor models.
Chen Y; Clark S; Wong T; Chen Y; Chen Y; Dennis MS; Luis E; Zhong F; Bheddah S; Koeppen H; Gogineni A; Ross S; Polakis P; Mallet W
Cancer Res; 2007 May; 67(10):4924-32. PubMed ID: 17510422
[TBL] [Abstract][Full Text] [Related]
9. [Expression and purification of mucin 16 and preparation and characterization of anti-mucin 16 monoclonal antibody].
Yang Y; Ding YT; Gong HT; Yu ZJ; Li XT
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Sep; 28(9):960-3. PubMed ID: 22980662
[TBL] [Abstract][Full Text] [Related]
10. Expression and epitope characterization of a recombinant CA 125 repeat: fourth report from the ISOBM TD-1 workshop.
Warren DJ; Nustad K; Beard JB; O'Brien TJ
Tumour Biol; 2009; 30(2):51-60. PubMed ID: 19321947
[TBL] [Abstract][Full Text] [Related]
11. How to overcome the disturbing effects of human anti-mouse antibodies (HAMA) on in vitro assays.
Oltrogge JB; Baum RP; Lema KN; Donnerstag B; Hör G
Int J Biol Markers; 1997; 12(1):15-7. PubMed ID: 9176712
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to murine monoclonal antibody-B43.13 correlate with prolonged survival of women with recurrent ovarian cancer.
Möbus VJ; Baum RP; Bolle M; Kreienberg R; Noujaim AA; Schultes BC; Nicodemus CF
Am J Obstet Gynecol; 2003 Jul; 189(1):28-36. PubMed ID: 12861134
[TBL] [Abstract][Full Text] [Related]
13. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas.
Sonoda K; Nakashima M; Kaku T; Kamura T; Nakano H; Watanabe T
Cancer; 1996 Apr; 77(8):1501-9. PubMed ID: 8608535
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of human ovarian carcinoma with OvaRex MAb-B43.13 in a human-PBL-SCID/BG mouse model.
Schultes BC; Zhang C; Xue LY; Noujaim AA; Madiyalakan R
Hybridoma; 1999 Feb; 18(1):47-55. PubMed ID: 10211788
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
[TBL] [Abstract][Full Text] [Related]
16. HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.
Suzuki N; Aoki D; Tamada Y; Susumu N; Orikawa K; Tsukazaki K; Sakayori M; Suzuki A; Fukuchi T; Mukai M; Kojima-Aikawa K; Ishida I; Nozawa S
Gynecol Oncol; 2004 Nov; 95(2):290-8. PubMed ID: 15491748
[TBL] [Abstract][Full Text] [Related]
17. Construction and expression of a single chain antibody mimicing human ovarian cancer antigen CA125.
Li AD; Li Z; Wang YH; Zhang YM; Ma J
Cell Mol Immunol; 2006 Feb; 3(1):59-62. PubMed ID: 16549051
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of a bispecific single-chain antibody directed against T cells and ovarian carcinoma.
Kriangkum J; Xu B; Gervais C; Paquette D; Jacobs FA; Martin L; Suresh MR
Hybridoma; 2000 Feb; 19(1):33-41. PubMed ID: 10768839
[TBL] [Abstract][Full Text] [Related]
19. CA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patients.
Gordon AN; Schultes BC; Gallion H; Edwards R; Whiteside TL; Cermak JM; Nicodemus CF
Gynecol Oncol; 2004 Aug; 94(2):340-51. PubMed ID: 15297171
[TBL] [Abstract][Full Text] [Related]
20. Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial cancer cells.
Xu FJ; Yu YH; Li BY; Moradi M; Elg S; Lane C; Carson L; Ramakrishnan S
Cancer Res; 1991 Aug; 51(15):4012-9. PubMed ID: 1855217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
